Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results
|
Dicerna Pharmaceuticals Inc (DRNA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2020 |
GN
| VBL Therapeutics Announces Appointment of Marc Kozin as Vice Chairman of Board of Directors |
02/05/2019 |
GN
| Recent Analysis Shows DICK'S Sporting Goods, Zix, Q2, InfraREIT, The Boston Beer, and Dicerna Pharmaceuticals Market Influences — Renewed Outlook, Key Drivers of Growth |
11/30/2018 |
GN
| Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture — Research Highlights Growth, Revenue, and Consolidated Results |
08/29/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications |
07/25/2018 |
GN
| Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals — Future Expectations, Projections Moving into 2018 |
05/18/2018 |
GN
| Research Report Identifies Carolina Financial, Dicerna Pharmaceuticals, On Assignment, Digimarc, CIRCOR International, and Nordson with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
05/14/2018 |
BW
| Dicerna Reports First Quarter 2018 Financial and Operating Results and Provides Corporate Update |
05/07/2018 |
BW
| Dicerna to Report First Quarter 2018 Financial Results and Host Conference Call on May 14, 2018 |
03/08/2018 |
BW
| Dicerna Reports Fourth Quarter and Year End 2017 Financial and Operating Results and Provides Corporate Update |
03/01/2018 |
BW
| Dicerna to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on March 8, 2018 |
01/24/2018 |
GN
| Analysis: Positioning to Benefit within Ferroglobe, Corbus Pharmaceuticals, Meritage, Dicerna Pharmaceuticals, Castle Brands, and Ply Gem — Research Highlights Growth, Revenue, and Consolidated Results |
11/02/2017 |
BW
| Dicerna Reports Third Quarter 2017 Financial and Operating Results and Provides Corporate Update |
10/26/2017 |
BW
| Dicerna to Report Third Quarter 2017 Financial Results and Host Conference Call on November 2, 2017 |
|
|